Jane Street’s Silexion Therapeutics Warrant SLXNW Stock Holding History

Jane Street’s Portfolio SLXNW Stock Details SLXNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.28K	Hold	74,910	–	–	﹤0.01%	11363
2026 Q1	$1.52K	Hold	74,910	–	–	﹤0.01%	11387
2025 Q4	$1.95K	Hold	74,910	–	–	﹤0.01%	10925
2025 Q3	$2.64K	Hold	74,910	–	–	﹤0.01%	10627
2025 Q2	$3.06K	Sell	74,910 -392	-0.5%	-$21	﹤0.01%	9453
2025 Q1	$5.76K	Sell	75,302 -419	-0.6%	-$26	﹤0.01%	9231
2024 Q4	$2.57K	Hold	75,721	–	–	﹤0.01%	9240
2024 Q3	$2.4K	Buy	+75,721	New	+$4.38K	﹤0.01%	9434

Other funds holding SLXNW

OMC

Oasis Management Company Grand Cayman, Cayman Islands $1.88B AUM 54.21% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return

Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

SBLIC

Security Benefit Life Insurance Company Topeka, Kansas $182M AUM 31.21% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Kepos Capital New York $73.4M AUM 4.78% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

PMAM

Picton Mahoney Asset Management Toronto, Ontario, Canada $13.5B AUM 51.46% 1-Year Est. Return

Jane Street's SLXNW Position: Q2 2026 in Review

Jane Street held its Silexion Therapeutics Warrant (SLXNW) position steady in Q2 2026 at 74,910 shares worth $2.28K. The position accounts for ﹤0.01% of the portfolio, ranked #11363.

Jane Street first reported a position in SLXNW in Q3 2024 and has held it in 8 quarters since. The position peaked at $5.76K in Q1 2025. 19 funds tracked by Wall St. Rank hold SLXNW as of Q2 2026.

Jane Street held 74,910 shares of Silexion Therapeutics Warrant worth $2.28K as of Q2 2026.
Jane Street left its Silexion Therapeutics Warrant share count unchanged in Q2 2026.
Silexion Therapeutics Warrant made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #11363 holding.
Jane Street first reported a position in Silexion Therapeutics Warrant in Q3 2024 and has held it in 8 quarters since.
Jane Street's Silexion Therapeutics Warrant position peaked at $5.76K in Q1 2025.
19 funds tracked by Wall St. Rank held Silexion Therapeutics Warrant as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.